![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » EXACTECH ANNOUNCES FDA CLEARANCE FOR U.S. DISTRIBUTION OF INTERSPACE SHOULDER PRE-FORMED ANTIBIOTIC BONE CEMENT SPACER
EXACTECH ANNOUNCES FDA CLEARANCE FOR U.S. DISTRIBUTION OF INTERSPACE SHOULDER PRE-FORMED ANTIBIOTIC BONE CEMENT SPACER
June 19, 2006
Exactech, Inc., a developer and producer of bone and joint restoration products including orthopaedic implants and biologic
materials, announced today that the U.S. Food and Drug dministration (FDA) has cleared for distribution the only pre-formed cement shoulder spacer containing antibiotic available in the United States.
Yahoo
News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct